Gastroenterology
Volume 138, Issue 1 , Pages 52-64 , January 2010

Radioembolization for Hepatocellular Carcinoma Using Yttrium-90 Microspheres: A Comprehensive Report of Long-term Outcomes

  • Riad Salem

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois
    • Division of Transplant Surgery, Department of Surgery, Northwestern Memorial Hospital, Chicago, Illinois
    • Corresponding Author InformationReprint requests Address requests for reprints to: Riad Salem, MD, MBA, Department of Radiology, 676 North St Clair, Suite 800, Chicago, Illinois 60611. fax: (312) 695-0654; or Laura Kulik, MD, Division of Hepatology, Department of Medicine, 675 North St Clair, Galter 15-250, Chicago, Illinois 60611.
    • ,
  • Robert J. Lewandowski

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Mary F. Mulcahy

      Affiliations

    • Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Ahsun Riaz

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Robert K. Ryu

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Saad Ibrahim

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Bassel Atassi

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Talia Baker

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Vanessa Gates

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Frank H. Miller

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Kent T. Sato

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Ed Wang

      Affiliations

    • Division of Transplant Surgery, Department of Surgery, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Ramona Gupta

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Al B. Benson

      Affiliations

    • Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Steven B. Newman

      Affiliations

    • Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Reed A. Omary

      Affiliations

    • Section of Interventional Radiology, Department of Radiology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Michael Abecassis

      Affiliations

    • Division of Hematology and Oncology, Northwestern Memorial Hospital, Chicago, Illinois
    • ,
  • Laura Kulik

      Affiliations

    • Division of Hepatology, Department of Medicine, Robert H. Lurie Comprehensive Cancer Center, Northwestern Memorial Hospital, Chicago, Illinois

Received 8 June 2009 ,Accepted 8 September 2009.

References 

  1. Parkin DM, Bray F, Ferlay J, et al. Global cancer statistics, 2002. CA Cancer J Clin. 2005;55:74–108
  2. Bosch FX, Ribes J, Diaz M, et al. Primary liver cancer: worldwide incidence and trends. Gastroenterology. 2004;127:S5–S16
  3. Mazzaferro V, Regalia E, Doci R, et al. Liver transplantation for the treatment of small hepatocellular carcinomas in patients with cirrhosis. N Engl J Med. 1996;334:693–699
  4. Kulik LM, Atassi B, van Holsbeeck L, et al. Yttrium-90 microspheres (TheraSphere(R)) treatment of unresectable hepatocellular carcinoma: downstaging to resection, RFA and bridge to transplantation. J Surg Oncol. 2006;94:572–586
  5. Lu DS, Yu NC, Raman SS, et al. Radiofrequency ablation of hepatocellular carcinoma: treatment success as defined by histologic examination of the explanted liver. Radiology. 2005;234:954–960
  6. Maddala YK, Stadheim L, Andrews JC, et al. Drop-out rates of patients with hepatocellular cancer listed for liver transplantation: outcome with chemoembolization. Liver Transpl. 2004;10:449–455
  7. Bruix J, Sherman M. Management of hepatocellular carcinoma. Hepatology. 2005;42:1208–1236
  8. Llovet JM, Real MI, Montana X, et al. Arterial embolisation or chemoembolisation versus symptomatic treatment in patients with unresectable hepatocellular carcinoma: a randomised controlled trial. Lancet. 2002;359:1734–1739
  9. Cheng AL, Kang YK, Chen Z, et al. Efficacy and safety of sorafenib in patients in the Asia-Pacific region with advanced hepatocellular carcinoma: a phase III randomised, double-blind, placebo-controlled trial. Lancet Oncol. 2009;10:25–34
  10. Llovet JM, Ricci S, Mazzaferro V, et al. Sorafenib in advanced hepatocellular carcinoma. N Engl J Med. 2008;359:378–390
  11. Ingold JA, Reed GB, Kaplan HS, et al. Radiation hepatitis. Am J Roentgenol Radium Ther Nucl Med. 1965;93:200–208
  12. Dawson LA, McGinn CJ, Lawrence TS. Conformal chemoradiation for primary and metastatic liver malignancies. Semin Surg Oncol. 2003;21:249–255
  13. Kennedy AS, Nutting C, Coldwell D, et al. Pathologic response and microdosimetry of (90)Y microspheres in man: review of four explanted whole livers. Int J Radiat Oncol Biol Phys. 2004;60:1552–1563
  14. Sato K, Lewandowski RJ, Bui JT, et al. Treatment of unresectable primary and metastatic liver cancer with yttrium-90 microspheres (TheraSphere(R)): assessment of hepatic arterial embolization. Cardiovasc Intervent Radiol. 2006;29:522–529
  15. Sala M, Llovet JM, Vilana R, et al. Initial response to percutaneous ablation predicts survival in patients with hepatocellular carcinoma. Hepatology. 2004;40:1352–1360
  16. Bruix J, Sherman M, Llovet JM, et al. Clinical management of hepatocellular carcinoma (Conclusions of the Barcelona-2000 EASL Conference. European Association for the Study of the Liver). J Hepatol. 2001;35:421–430
  17. Llovet JM, Di Bisceglie AM, Bruix J, et al. Design and endpoints of clinical trials in hepatocellular carcinoma. J Natl Cancer Inst. 2008;100:698–711
  18. Llovet JM, Fuster J, Bruix J. The Barcelona approach: diagnosis, staging, and treatment of hepatocellular carcinoma. Liver Transpl. 2004;10:S115–S120
  19. Llovet JM, Burroughs A, Bruix J. Hepatocellular carcinoma. Lancet. 2003;362:1907–1917
  20. Katyal S, Oliver JH, Peterson MS, et al. Extrahepatic metastases of hepatocellular carcinoma. Radiology. 2000;216:698–703
  21. Leung TW, Lau WY, Ho SK, et al. Radiation pneumonitis after selective internal radiation treatment with intraarterial 90yttrium-microspheres for inoperable hepatic tumors. Int J Radiat Oncol Biol Phys. 1995;33:919–924
  22. TheraSphere Yttrium-90 microspheres. [package insert] Kanata, Canada: MDS Nordion; 2004;
  23. Salem R, Thurston KG. Radioembolization with 90Yttrium microspheres: a state-of-the-art brachytherapy treatment for primary and secondary liver malignancies: part 1: technical and methodologic considerations. J Vasc Interv Radiol. 2006;17:1251–1278
  24. Miller AB, Hoogstraten B, Staquet M, et al. Reporting results of cancer treatment. Cancer. 1981;47:207–214
  25. Takayasu K, Arii S, Ikai I, et al. Prospective cohort study of transarterial chemoembolization for unresectable hepatocellular carcinoma in 8510 patients. Gastroenterology. 2006;131:461–469
  26. Kaplan EL, Meier P. Nonparametric estimation from incomplete observations. J Am Stat Assoc. 1958;53:457–481
  27. Geschwind JF, Salem R, Carr BI, et al. Yttrium-90 microspheres for the treatment of hepatocellular carcinoma. Gastroenterology. 2004;127:S194–S205
  28. Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: factors associated with liver toxicities. J Vasc Interv Radiol. 2005;16:205–213
  29. Goin JE, Salem R, Carr BI, et al. Treatment of unresectable hepatocellular carcinoma with intrahepatic yttrium 90 microspheres: a risk-stratification analysis. J Vasc Interv Radiol. 2005;16:195–203
  30. Murthy R, Brown DB, Salem R, et al. Gastrointestinal complications associated with hepatic arterial Yttrium-90 microsphere therapy. J Vasc Interv Radiol. 2007;18:553–561quiz 562
  31. Rhee TK, Naik NK, Deng J, et al. Tumor response after yttrium-90 radioembolization for hepatocellular carcinoma: comparison of diffusion-weighted functional MR imaging with anatomic MR imaging. J Vasc Interv Radiol. 2008;19:1180–1186
  32. Salem R, Lewandowski RJ, Atassi B, et al. Treatment of unresectable hepatocellular carcinoma with use of 90Y microspheres (TheraSphere): safety, tumor response, and survival. J Vasc Interv Radiol. 2005;16:1627–1639
  33. Thomas MB, O'Beirne JP, Furuse J, et al. Systemic therapy for hepatocellular carcinoma: cytotoxic chemotherapy, targeted therapy and immunotherapy. Ann Surg Oncol. 2008;15:1008–1014
  34. Abou-Alfa GK, Schwartz L, Ricci S, et al. Phase II study of sorafenib in patients with advanced hepatocellular carcinoma. J Clin Oncol. 2006;24:4293–4300
  35. Keppke AL, Salem R, Reddy D, et al. Imaging of hepatocellular carcinoma after treatment with yttrium-90 microspheres. AJR Am J Roentgenol. 2007;188:768–775
  36. Lo CM, Ngan H, Tso WK, et al. Randomized controlled trial of transarterial lipiodol chemoembolization for unresectable hepatocellular carcinoma. Hepatology. 2002;35:1164–1171
  37. Yao FY, Hirose R, LaBerge JM, et al. A prospective study on downstaging of hepatocellular carcinoma prior to liver transplantation. Liver Transpl. 2005;11:1505–1514
  38. Moylan CA, Brady CW, Johnson JL, et al. Disparities in liver transplantation before and after introduction of the MELD score. JAMA. 2008;300:2371–2378
  39. Prieto J. Inflammation, HCC and sex: IL-6 in the centre of the triangle. J Hepatol. 2008;48:380–381
  40. Calvet X, Bruix J, Gines P, et al. Prognostic factors of hepatocellular carcinoma in the west: a multivariate analysis in 206 patients. Hepatology. 1990;12:753–760
  41. Giannini E, Romagnoli P, Fasoli A, et al. Influence of age on clinical presentation, therapeutic options, and prognosis in anti-HCV positive cirrhotic patients with hepatocellular carcinoma. Age Ageing. 2002;31:457–462
  42. Lok AS, Seeff LB, Morgan TR, et al. Incidence of hepatocellular carcinoma and associated risk factors in hepatitis C-related advanced liver disease. Gastroenterology. 2009;136:138–148
  43. Arii S, Yamaoka Y, Futagawa S, et al. Results of surgical and nonsurgical treatment for small-sized hepatocellular carcinomas: a retrospective and nationwide survey in Japan (The Liver Cancer Study Group of Japan). Hepatology. 2000;32:1224–1229
  44. Tol J, Koopman M, Cats A, et al. Chemotherapy, bevacizumab, and cetuximab in metastatic colorectal cancer. N Engl J Med. 2009;360:563–572
  45. Hecht JR, Mitchell E, Chidiac T, et al. A randomized phase IIIB trial of chemotherapy, bevacizumab, and panitumumab compared with chemotherapy and bevacizumab alone for metastatic colorectal cancer. J Clin Oncol. 2009;27:672–680
  46. Riaz A, Kulik L, Lewandowski RJ, et al. Radiologic-pathologic correlation of hepatocellular carcinoma treated with internal radiation using yttrium-90 microspheres. Hepatology. 2009;49:1185–1193

 Conflicts of interest The authors disclose the following: Dr Salem is an advisor to and receives research support from MDS Nordion. Dr Mulcahy and Dr Benson receive research support from MDS Nordion. Dr Lewandowski, Dr Riaz, Dr Ryu, Dr Ibrahim, Dr Atassi, Dr Baker, Dr Gates, Dr Miller, Dr Sato, Dr Wang, Dr Gupta, Dr Newman, Dr Omary, Dr Abecassis, and Dr Kulik disclose no conflicts.

PII: S0016-5085(09)01574-1

doi: 10.1053/j.gastro.2009.09.006

Gastroenterology
Volume 138, Issue 1 , Pages 52-64 , January 2010

Article Tools

* Image Usage & Resolution